1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage/Taxonomy
2.2. Market Definition/Scope/Limitations
2.3. Inclusion & Exclusion
3. Key Market Trends
3.1. Key Trends Impacting The Market
3.2. Innovation/Development Trends
4. Market Background
4.1. Macro-Economic Factors
4.1.1. Global GDP Growth Outlook
4.1.2. Global Healthcare Expenditure Outlook
4.1.3. Regional Healthcare Market Outlook
4.2. Forecast Factors - Relevance & Impact
4.2.1. Rising focus on Research and Development
4.2.2. Rising prevalence of antimicrobial-resistance infection
4.2.3. Increasing Use of Antibiotics
4.2.4. Wide Range of Indication of Bacteriophage
4.2.5. Rising Use of Bacteriophage as Vaccine Vehicles
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity Analysis
5. COVID19 Crisis Analysis
5.1. Current COVID19 Statistics and Probable Future Impact
5.2. Current GDP Projection and Probable Impact
5.3. Current Economic Projection as compared to 2008 Economic analysis
5.4. COVID19 and Impact Analysis
5.4.1. By Product
5.4.2. By Route of Administration
5.4.3. By Application
5.4.4. By Distribution Channel
5.4.5. By Country
6. Key Success Factors
6.1. Antibiotics vs. Bacteriophage Therapy
6.2. Disease Epidemiology
6.3. Regulatory Scenario
6.4. Pipeline Analysis
6.5. Key Strategies by Manufacturers
6.6. PESTEL Analysis
6.7. PORTAL Analysis
7. Global Bacteriophage Market Demand (in Value or Size in US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031
7.1. Historical Market Value (US$ Mn) Analysis, 2016-2020
7.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Bacteriophage Market Analysis 2016-2020 and Forecast 2021-2031, by Product
8.1. Introduction/Key Findings
8.2. Historical Market Size (US$ Mn) Analysis by Product, 2016-2020
8.3. Current and Future Market Size (US$ Mn) and Forecast by Product, 2021-2031
8.3.1. Phage Probiotics
8.3.2. Phage Therapeutics
8.4. Market Attractiveness Analysis by Product
9. Global Bacteriophage Market Analysis 2016-2020 and Forecast 2021-2031, by Route of Administration
9.1. Introduction/Key Findings
9.2. Historical Market Size (US$ Mn) Analysis by Usage, 2016-2020
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Route of Administration, 2021-2031
9.3.1. Oral
9.3.2. Topical
9.3.3. Others
9.4. Market Attractiveness Analysis by Route of Administration
10. Global Bacteriophage Market Analysis 2016-2020 and Forecast 2021-2031, by Application
10.1. Introduction/Key Findings
10.2. Historical Market Size (US$ Mn) Analysis by Application, 2016-2020
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Application, 2021-2031
10.3.1. Gastroenterology
10.3.2. Respiratory infections treatment
10.3.3. Skin infection treatment
10.3.4. Wound prophylaxis
10.3.5. Urogenital infection treatment
10.3.6. Others
10.4. Market Attractiveness Analysis by Application
11. Global Bacteriophage Market Analysis 2016-2020 and Forecast 2021-2031, by Distribution Channel
11.1. Introduction/Key Findings
11.2. Historical Market Size (US$ Mn) Analysis by Distribution Channel, 2016-2020
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Distribution Channel, 2021-2031
11.3.1. Retail Pharmacies
11.3.2. Hospital Pharmacies
11.3.3. Online Pharmacies
11.4. Market Attractiveness Analysis by Distribution Channel
12. Global Bacteriophage Market Analysis 2016-2020 and Forecast 2021-2031, by Region
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis by Region, 2016-2020
12.3. Current Market Size (US$ Mn) Analysis and Forecast by Region, 2021-2031
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. Middle East and Africa (MEA)
12.3.5. South Asia
12.3.6. East Asia
12.3.7. Oceania
12.4. Market Attractiveness Analysis by Region
13. North America Bacteriophage Market Analysis 2016-2020 and Forecast 2021-2031
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016-2020
13.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2021-2031
13.3.1. By Country
13.3.1.1. U.S.
13.3.1.2. Canada
13.3.2. By Product
13.3.3. By Route of Administration
13.3.4. By Application
13.3.5. By Distribution Channel
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Distribution Channel
13.5. Key Market Participants - Intensity Mapping
13.6. Drivers and Restraints - Impact Analysis
14. Latin America Bacteriophage Market 2016-2020 and Forecast 2021-2031
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016-2020
14.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2021-2031
14.3.1. By Country
14.3.1.1. Brazil
14.3.1.2. Mexico
14.3.1.3. Argentina
14.3.1.4. Rest of Latin America
14.3.2. By Product
14.3.3. By Route of Administration
14.3.4. By Application
14.3.5. By Distribution Channel
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Distribution Channel
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
15. Europe Bacteriophage Market 2016-2020 and Forecast 2021-2031
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016-2020
15.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2021-2031
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. Italy
15.3.1.3. France
15.3.1.4. U.K.
15.3.1.5. Spain
15.3.1.6. Poland
15.3.1.7. Russia
15.3.1.8. Rest of Europe
15.3.2. By Product
15.3.3. By Route of Administration
15.3.4. By Application
15.3.5. By Distribution Channel
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Route of Administration
15.4.4. By Application
15.4.5. By Distribution Channel
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
16. South Asia Bacteriophage Market 2016-2020 and Forecast 2021-2031
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016-2020
16.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2021-2031
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Thailand
16.3.1.3. Indonesia
16.3.1.4. Malaysia
16.3.1.5. Rest of South Asia
16.3.2. By Product
16.3.3. By Route of Administration
16.3.4. By Application
16.3.5. By Distribution Channel
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Distribution Channel
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
17. East Asia Bacteriophage Market 2016-2020 and Forecast 2021-2031
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016-2020
17.4. Market Size (US$ Mn) Forecast by Market Taxonomy, 2021-2031
17.4.1. By Country
17.4.1.1. China
17.4.1.2. Japan
17.4.1.3. South Korea
17.4.2. By Product
17.4.3. By Route of Administration
17.4.4. By Application
17.4.5. By Distribution Channel
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Distribution Channel
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
18. Oceania Bacteriophage Market 2016-2020 and Forecast 2021-2031
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016-2020
18.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2021-2031
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Product
18.3.3. By Route of Administration
18.3.4. By Application
18.3.5. By Distribution Channel
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Distribution Channel
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
19. Middle East and Africa Bacteriophage Market 2016-2020 and Forecast 2021-2031
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016-2020
19.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2021-2031
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. South Africa
19.3.1.3. Turkey
19.3.1.4. Rest of Middle East and Africa
19.3.2. By Product
19.3.3. By Route of Administration
19.3.4. By Application
19.3.5. By Distribution Channel
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Distribution Channel
19.5. Key Market Participants - Intensity Mapping
19.6. Drivers and Restraints - Impact Analysis
20. Country Level Bacteriophage Market Analysis 2021 & 2031
20.1. Introduction
20.1.1. Market Value Proportion Analysis
20.1.2. Global VS. Country Growth Comparison
20.2. U.S. Bacteriophage Market Analysis
20.2.1. By Distribution Channel
20.3. Canada Bacteriophage Market Analysis
20.3.1. By Distribution Channel
20.4. Mexico Bacteriophage Market Analysis
20.4.1. By Distribution Channel
20.5. Brazil Bacteriophage Market Analysis
20.5.1. By Distribution Channel
20.6. Argentina Bacteriophage Market Analysis
20.6.1. By Distribution Channel
20.7. U.K Bacteriophage Market Analysis
20.7.1. By Distribution Channel
20.8. Germany Bacteriophage Market Analysis
20.8.1. By Distribution Channel
20.9. Italy Bacteriophage Market Analysis
20.9.1. By Distribution Channel
20.10. France Bacteriophage Market Analysis
20.10.1. By Distribution Channel
20.11. Poland Bacteriophage Market Analysis
20.11.1. By Product
20.11.2. By Route of Administration
20.11.3. By Application
20.11.4. By Distribution Channel
20.12. Spain Bacteriophage Market Analysis
20.12.1. By Distribution Channel
20.13. Georgia Bacteriophage Market Analysis
20.13.1. By Product
20.13.2. By Route of Administration
20.13.3. By Application
20.13.4. By Distribution Channel
20.14. Russia Bacteriophage Market Analysis
20.14.1. By Product
20.14.2. By Route of Administration
20.14.3. By Application
20.14.4. By Distribution Channel
20.15. China Bacteriophage Market Analysis
20.15.1. By Distribution Channel
20.16. Japan Bacteriophage Market Analysis
20.16.1. By Distribution Channel
20.17. South Korea Bacteriophage Market Analysis
20.17.1. By Distribution Channel
20.18. India Bacteriophage Market Analysis
20.18.1. By Distribution Channel
20.19. Thailand Bacteriophage Market Analysis
20.19.1. By Distribution Channel
20.20. Malaysia Bacteriophage Market Analysis
20.20.1. By Distribution Channel
20.21. Indonesia Bacteriophage Market Analysis
20.21.1. By Distribution Channel
20.22. Australia Bacteriophage Market Analysis
20.22.1. By Distribution Channel
20.23. New Zealand Bacteriophage Market Analysis
20.23.1. By Distribution Channel
20.24. Turkey Bacteriophage Market Analysis
20.24.1. By Distribution Channel
20.25. GCC Countries Bacteriophage Market Analysis
20.25.1. By Distribution Channel
20.26. North Africa Bacteriophage Market Analysis
20.26.1. By Distribution Channel
20.27. South Africa Bacteriophage Market Analysis
20.27.1. By Distribution Channel
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Presence Analysis
21.3.1. By Regional footprint of players
21.3.2. Product footprint of players
21.3.3. Channel footprint of players
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive
22.3.1. Life Extension
22.3.1.1. Overview & Key Financials
22.3.1.2. Product Portfolio
22.3.1.3. Sales Footprint
22.3.1.4. SWOT Analysis
22.3.1.5. Strategy
22.3.1.5.1. Marketing Strategy
22.3.1.5.2. Product Strategy
22.3.1.5.3. Channel Strategy
22.3.2. Arthur Andrew Medical
22.3.2.1. Overview & Key Financials
22.3.2.2. Product Portfolio
22.3.2.3. Sales Footprint
22.3.2.4. SWOT Analysis
22.3.2.5. Strategy
22.3.2.5.1. Marketing Strategy
22.3.2.5.2. Product Strategy
22.3.2.5.3. Channel Strategy
22.3.3. Deerland Probiotics & Enzymes Inc.
22.3.3.1. Overview & Key Financials
22.3.3.2. Product Portfolio
22.3.3.3. Sales Footprint
22.3.3.4. SWOT Analysis
22.3.3.5. Strategy
22.3.3.5.1. Marketing Strategy
22.3.3.5.2. Product Strategy
22.3.3.5.3. Channel Strategy
22.3.4. BioChimpharm
22.3.4.1. Overview & Key Financials
22.3.4.2. Product Portfolio
22.3.4.3. Sales Footprint
22.3.4.4. SWOT Analysis
22.3.4.5. Strategy
22.3.4.5.1. Marketing Strategy
22.3.4.5.2. Product Strategy
22.3.4.5.3. Channel Strategy
22.3.5. Micreos Human Health
22.3.5.1. Overview & Key Financials
22.3.5.2. Product Portfolio
22.3.5.3. Sales Footprint
22.3.5.4. SWOT Analysis
22.3.5.5. Strategy
22.3.5.5.1. Marketing Strategy
22.3.5.5.2. Product Strategy
22.3.5.5.3. Channel Strategy
22.3.6. Designs for Health
22.3.6.1. Overview & Key Financials
22.3.6.2. Product Portfolio
22.3.6.3. Sales Footprint
22.3.6.4. SWOT Analysis
22.3.6.5. Strategy
22.3.6.5.1. Marketing Strategy
22.3.6.5.2. Product Strategy
22.3.6.5.3. Channel Strategy
22.3.7. Accelerated Health Systems llc
22.3.7.1. Overview & Key Financials
22.3.7.2. Product Portfolio
22.3.7.3. Sales Footprint
22.3.7.4. SWOT Analysis
22.3.7.5. Strategy
22.3.7.5.1. Marketing Strategy
22.3.7.5.2. Product Strategy
22.3.7.5.3. Channel Strategy
22.3.8. The biostation
22.3.8.1. Overview & Key Financials
22.3.8.2. Product Portfolio
22.3.8.3. Sales Footprint
22.3.8.4. SWOT Analysis
22.3.8.5. Strategy
22.3.8.5.1. Marketing Strategy
22.3.8.5.2. Product Strategy
22.3.8.5.3. Channel Strategy
22.3.9. Probiotic America
22.3.9.1. Overview & Key Financials
22.3.9.2. Product Portfolio
22.3.9.3. Sales Footprint
22.3.9.4. SWOT Analysis
22.3.9.5. Strategy
22.3.9.5.1. Marketing Strategy
22.3.9.5.2. Product Strategy
22.3.9.5.3. Channel Strategy
22.3.10. Microgen
22.3.10.1. Overview & Key Financials
22.3.10.2. Product Portfolio
22.3.10.3. Sales Footprint
22.3.10.4. SWOT Analysis
22.3.10.5. Strategy
22.3.10.5.1. Marketing Strategy
22.3.10.5.2. Product Strategy
22.3.10.5.3. Channel Strategy
22.3.11. IntraLytix Inc.
22.3.11.1. Overview & Key Financials
22.3.11.2. Product Portfolio
22.3.11.3. Sales Footprint
22.3.11.4. SWOT Analysis
22.3.11.5. Strategy
22.3.11.5.1. Marketing Strategy
22.3.11.5.2. Product Strategy
22.3.11.5.3. Channel Strategy
